Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
25 hedge funds and large institutions have $3.61M invested in Sophiris Bio, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.
3% less call options, than puts
Call options by funds: $131K | Put options by funds: $135K
11% less capital invested
Capital invested by funds: $4.07M → $3.61M (-$457K)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
19% less funds holding
Funds holding: 31 → 25 (-6)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$92.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$76.1K |
| 3 |
VF
Virtu Financial
New York
|
+$71.8K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$22.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$183K |
| 2 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
-$120K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$84K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$50K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$46.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MFIM
26
Mesirow Financial Investment Management
Chicago,
Illinois
| – | -$120K | -54,510 | Closed |
|
|
GCP
27
GSA Capital Partners
London,
United Kingdom
| – | -$84K | -38,400 | Closed |
|
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$46.3K | -22,337 | Closed |
|
29
Group One Trading
Chicago,
Illinois
| – | -$40.2K | -19,388 | Closed |
|
30
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$21.6K | -10,400 | -98% |
|
31
Creative Planning
Overland Park,
Kansas
| – | -$11K | -4,900 | Closed |
|
|
AIM
32
Acrospire Investment Management
Chicago,
Illinois
| – | -$9K | -4,034 | Closed |
|
SPHS Hedge Fund Activity: Q3 2017 in Review
25 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2017, worth a combined $3.61M — down 11% from $4.07M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SPHS and 3 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $92.8K. The largest seller was Squarepoint, exiting entirely with an estimated $183K sold.
- 25 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2017, down from 31 in Q2 2017.
- Funds reported $3.61M of Sophiris Bio, Inc. stock for Q3 2017, down 11% quarter-over-quarter.
- 3 funds opened new Sophiris Bio, Inc. positions in Q3 2017 and 8 closed out, a net change of -5 holders.
- The largest Sophiris Bio, Inc. buyer in Q3 2017 was Vanguard Group, an estimated $92.8K added.
- The largest Sophiris Bio, Inc. seller in Q3 2017 was Squarepoint, an estimated $183K sold.
Based on aggregated 13F filings for Q3 2017.